Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.805 USD | +1.26% | -1.05% | -31.17% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.17% | 367M | |
+42.48% | 54.04B | |
+43.57% | 41.96B | |
-1.33% | 41.92B | |
-7.59% | 28.35B | |
+11.69% | 26.35B | |
-22.37% | 19B | |
+7.85% | 13B | |
+28.70% | 12.28B | |
+25.80% | 12.19B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q2 Revenue $117.3M, vs. Street Est of $115.1M